UPPSALA, Sweden, May 24, 2022 / B3C newswire / -- Biotage is pleased to announce the launch of Biotage® Selekt Enkel, a new addition to the Biotage family of flash purification systems. The Biotage® Enkel is a dedicated, purification workhorse, with a modular design that facilitates application customization. It also utilizes the low solvent consumption workflow of the Biotage® Selekt family, for greener operation and greater sustainability.
Maintaining the small footprint and compact design of the existing systems, the new Biotage® Selekt Enkel is a reliable and robust instrument, designed to perform routine purifications in the drug discovery workflow with a reduced environmental impact. The system features one column lines and two solvent lines, enabling separations to be performed in either normal or reversed phases, using high-loading Biotage® Sfär flash columns.
Biotage® Selekt Enkel introduces a digitized approach to instrument design, with a novel modular construction. Laboratories can decide whether they wish to add optional features, such as automated handling of purified sample collection racks or an extended collection bed, and thus tailor the system to suit their particular workflow. The instrument utilizes the user-friendly and intuitive interface of the Biotage® Selekt family, making the instrument a powerful and efficient purification platform. Biotage® Selekt Enkel can also be upgraded with the Biotage® Spektra software package for additional enhanced functionality, leading to purer samples, reduced solvent use and more efficient operation.
“True to our strategy of providing chemists and scientists with scalable and sustainable solutions streamlining their workflows, the Biotage® Selekt Enkel enables end-users to tailor a solution that suits their workflow, while simultaneously reducing the use of solvents. Building on the success of the Biotage® Selekt system, this purification workhorse further improves our customers' efficiency and user-experience as well as contributing to a reduced environmental footprint and greater sustainability for all. As ever, Biotage is helping make the world healthier, greener and cleaner,” said Tomas Blomquist, CEO Biotage.
About Biotage
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing. Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited. Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability. Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Contact
Biotage GB Ltd.
James Churchill
Marketing Communications Manager - International
Distribution Way, Dyffryn Business Park
Ystrad Mynach, CF82 7TS
United Kingdom
T +44 (0)1443 811 849
M +44 (0) 7875 484778
This email address is being protected from spambots. You need JavaScript enabled to view it.
Keywords: Drug Discovery; Automation, Laboratory; Laboratories; Chemistry Techniques, Analytical; Analytic Sample Preparation Methods; Solid Phase Extraction; Solvents; Chromatography, High Pressure Liquid; Environment; Biotechnology; Technology, Pharmaceutical; Sweden
Published by B3C newswire